Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning
1 other identifier
observational
100
1 country
1
Brief Summary
This study investigates the longitudinal effects of brain stimulation treatments on decision-making and reward learning. Here, we use daily assessments of reinforcement learning behavior in patients with depression who receive neuromodulation treatment to study potential associations between changes in decision-making and reward learning and changes in clinical symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 10, 2026
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
September 16, 2026
September 1, 2026
1.9 years
September 10, 2026
September 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Punishment learning rates
The primary outcome are punishment learning rate estimates from a computational reinforcement learning model. Learning rates will be compared within and between stimulation conditions. Reinforcement learning is repeatedly measured with a bandit task with fluctuating reward probabilities (reward learning task). Reward learning behavior will be collected online over up to 60 runs, each including 150 trials.
Assessed online up to 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Secondary Outcomes (17)
Stimulation-induced mid-term changes in the backward digit span
Assessed before the first stimulation treatment and after 4 and 8 weeks (10 minutes).
Correct choices in the reward learning task
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Reward sensitivity
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Weighting of learned values and rewards at stake (lambda)
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Stimulation-induced mid-term changes in reward learning rates
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
- +12 more secondary outcomes
Other Outcomes (3)
Mood state
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Metabolic state
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Motivational state
Assessed online at least 5 times before the first stimulation treatment and daily throughout the study (8 weeks).
Study Arms (5)
Electroconvulsive therapy (ECT)
Participants receive ECT as a treatment within the clinic. ECT intentionally causes a generalized seizure by passing electrical currents through the brain under anesthesia. The treatment protocol (e.g., number of treatments) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.
Transcranial magnetic stimulation (TMS)
Participants receive TMS as a treatment within the clinic. TMS is a non-invasive procedure in which a magnetic coil is used to induce electrical currents in the brain and thus influence cortex activity. The treatment protocol (e.g., number of treatments, type of TMS) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.
invasive vagus nerve stimulation (VNS)
Participants receive VNS as a treatment within the clinic. VNS is a surgical treatment in which a stimulation device is implanted that sends electrical impulses to the vagus nerve. The treatment protocol (e.g., stimulation settings) is independent of study participation and follows the doctor's orders. Participants are enrolled after the treatment indication is confirmed.
transcutaneous vagus nerve stimulation (tVNS)
Participants receive tVNS as a treatment from the clinic for at home stimulation. To stimulate vagal afferents, the electrode will be placed at the cymba conchae of the right ear using a previously established conventional stimulation protocol (30s ON, 30s OFF; tVNS E device, tVNS Technologies GmbH, Erlangen, Germany). The stimulation can be applied for up to 4h per day and participants self-select stimulation time and duration based on the doctor's orders. Participants are enrolled after the treatment indication is confirmed.
Control
Participants receive an indication for a stimulation treatment within the clinic, but do not make use of it. Participants are included after treatment indication.
Eligibility Criteria
The study population consists of patients in the Department of Psychiatry and Psychotherapy at the University Hospital Bonn, who receive an indication for a brain stimulation treatment (ECT, TMS, VNS, taVNS).
You may qualify if:
- Indication for a brain stimulation treatment (ECT, TMS, VNS, taVNS) in the Department of Psychiatry and Psychotherapy at the University Hospital Bonn
- Be able and willing to provide informed consent.
You may not qualify if:
- Non-German speakers
- Unclear ability to give consent to the study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Nils B. Kroemerlead
- Department of Psychiatry University of Bonncollaborator
Study Sites (1)
Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn
Bonn, 53127, Germany
Related Publications (16)
Neuser MP, Kuhnel A, Krautlein F, Teckentrup V, Svaldi J, Kroemer NB. Reliability of gamified reinforcement learning in densely sampled longitudinal assessments. PLOS Digit Health. 2023 Sep 6;2(9):e0000330. doi: 10.1371/journal.pdig.0000330. eCollection 2023 Sep.
PMID: 37672521BACKGROUNDHuys QJM, Browning M. A Computational View on the Nature of Reward and Value in Anhedonia. Curr Top Behav Neurosci. 2022;58:421-441. doi: 10.1007/7854_2021_290.
PMID: 34935117BACKGROUNDKuehnel A, Zietz J, Theuer JK, Neuser MP, Kroemer NB; Dense sampling of choices links high learning rates to obesity and low reward sensitivity to binge eating; medRxiv; 2025 Jun 20
BACKGROUNDWeber I, Niehaus H, Krause K, Molitor L, Peper M, Schmidt L, Hakel L, Timmermann L, Menzler K, Knake S, Oehrn CR. Trust your gut: vagal nerve stimulation in humans improves reinforcement learning. Brain Commun. 2021 Mar 14;3(2):fcab039. doi: 10.1093/braincomms/fcab039. eCollection 2021.
PMID: 33928247BACKGROUNDTrapp NT, Purgianto A, Taylor JJ, Singh MK, Oberman LM, Mickey BJ, Youssef NA, Solzbacher D, Zebley B, Cabrera LY, Conroy S, Cristancho M, Richards JR, Flood MJ, Barbour T, Blumberger DM, Taylor SF, Feifel D, Reti IM, McClintock SM, Lisanby SH, Husain MM; National Network of Depression Centers Neuromodulation Task Group. Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2025 Feb;170:206-233. doi: 10.1016/j.clinph.2024.12.015. Epub 2024 Dec 19.
PMID: 39756350BACKGROUNDSubramanian S, Lopez R, Zorumski CF, Cristancho P. Electroconvulsive therapy in treatment resistant depression. J Neurol Sci. 2022 Mar 15;434:120095. doi: 10.1016/j.jns.2021.120095. Epub 2021 Dec 18.
PMID: 34979372BACKGROUNDPike AC, Robinson OJ. Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022 Apr 1;79(4):313-322. doi: 10.1001/jamapsychiatry.2022.0051.
PMID: 35234834BACKGROUNDLandry M, Moreno A, Patry S, Potvin S, Lemasson M. Current Practices of Electroconvulsive Therapy in Mental Disorders: A Systematic Review and Meta-Analysis of Short and Long-Term Cognitive Effects. J ECT. 2021 Jun 1;37(2):119-127. doi: 10.1097/YCT.0000000000000723.
PMID: 33009218BACKGROUNDKuhnel A, Teckentrup V, Neuser MP, Huys QJM, Burrasch C, Walter M, Kroemer NB. Stimulation of the vagus nerve reduces learning in a go/no-go reinforcement learning task. Eur Neuropsychopharmacol. 2020 Jun;35:17-29. doi: 10.1016/j.euroneuro.2020.03.023. Epub 2020 May 11.
PMID: 32404279BACKGROUNDKamel LY, Xiong W, Gott BM, Kumar A, Conway CR. Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression. J Neurol Sci. 2022 Mar 15;434:120171. doi: 10.1016/j.jns.2022.120171. Epub 2022 Jan 29.
PMID: 35158102BACKGROUNDHewitt SRC, Norbury A, Huys QJM, Hauser TU. Day-to-day fluctuations in motivation drive effort-based decision-making. Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2417964122. doi: 10.1073/pnas.2417964122. Epub 2025 Mar 17.
PMID: 40096607BACKGROUNDFerstl M, Kuhnel A, Klaus J, Lin WM, Kroemer NB. Non-invasive vagus nerve stimulation conditions increased invigoration and wanting in depression. Compr Psychiatry. 2024 Jul;132:152488. doi: 10.1016/j.comppsych.2024.152488. Epub 2024 Apr 16.
PMID: 38657358BACKGROUNDEspinoza RT, Kellner CH. Electroconvulsive Therapy. N Engl J Med. 2022 Feb 17;386(7):667-672. doi: 10.1056/NEJMra2034954. No abstract available.
PMID: 35172057BACKGROUNDConroy SK, Holtzheimer PE. Neuromodulation Strategies for the Treatment of Depression. Am J Psychiatry. 2021 Dec;178(12):1082-1088. doi: 10.1176/appi.ajp.2021.21101034.
PMID: 34855452BACKGROUNDBiernacki K, Myers CE, Cole S, Cavanagh JF, Baker TE. Prefrontal transcranial magnetic stimulation boosts response vigour during reinforcement learning in healthy adults. Eur J Neurosci. 2023 Feb;57(4):680-691. doi: 10.1111/ejn.15905. Epub 2022 Dec 30.
PMID: 36550631BACKGROUNDAmlung M, Marsden E, Holshausen K, Morris V, Patel H, Vedelago L, Naish KR, Reed DD, McCabe RE. Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders: A Meta-analysis. JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186. doi: 10.1001/jamapsychiatry.2019.2102.
PMID: 31461131BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nils B Kroemer, Prof. Dr.
Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. rer. nat.
Study Record Dates
First Submitted
September 10, 2026
First Posted
September 16, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
September 16, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Anonymized data will be shared upon publication of the results
- Access Criteria
- Until the data is publicly available, researchers may contact the lead PI to gain access.
After the publication of the key results of the study, anonymized data will be made publicly available (e.g., at osf.org).